See leaflet
See Risk Management Plan
Ornate®
eltrombopag
Indications
- Patients aged 1 year and above with primary immune thrombocytopenia (ITP) lasting 6 months or longer from diagnosis and who are refractory to other treatments (eg, corticosteroids, immunoglobulins)
- Adult patients with chronic hepatitis C virus (HCV) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy
- Adult patients with acquired severe aplastic anaemia (SAA) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation
Presentations
- 25 mg x 28 tablets
- 50 mg x 28 tablets
